![]() Karuna Therapeutics Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions. | ||
Founding Date | Founding Date 2000 | Founding Date 2009 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Helsingfors, FI HQ Frankfurt Am Main, DE Madison, US | Locations Boston, US HQ Boston, US Carmel, US |
Employees | Employees 40 | Employees 1919% increase |
Valuation ($) | Valuation ($) 40 m | Valuation ($) 12.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) €11m (FY, 2025) | Revenue (est.) $654k (FY, 2023) |
Net income | Net income €573k (FY, 2025) | Net income ($433.7m) (FY, 2023) |

Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions.
View company